PUMA BIOTECHNOLOGY, INC.
Balance Sheet
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $52.8M | $63.9M | $63.1M | $63.9M | $89.8M | $95.7M | $85.3M | $90.1M |
| Accounts Receivable | $34.0M | $27.0M | $32.5M | $23.8M | $30.5M | $26.2M | $25.5M | $27.1M |
| Inventory | $6.7M | $7.3M | $7.1M | $7.2M | $7.6M | $7.7M | $3.5M | $3.1M |
| Total Current Assets | $114.3M | $117.6M | $140.0M | $136.9M | $167.8M | $163.8M | $146.1M | $159.8M |
| Property, Plant & Equipment | $1.4M | $1.6M | $1.8M | $1.9M | $2.1M | $2.3M | $2.5M | $2.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $66.1M | — | — | — | $74.1M | — |
| Total Assets | $193.7M | $200.7M | $226.6M | $226.3M | $260.0M | $258.7M | $244.2M | $261.7M |
| Liabilities | ||||||||
| Accounts Payable | $9.8M | $7.4M | $11.2M | $20.0M | $11.2M | $10.7M | $12.1M | $12.5M |
| Total Current Liabilities | $56.8M | $74.8M | $109.6M | $116.3M | $137.9M | $140.4M | $114.3M | $118.2M |
| Long-Term Debt | $97.7M | $97.4M | $97.1M | $96.8M | $68.7M | $76.3M | $84.0M | $91.7M |
| Total Liabilities | $173.9M | $193.5M | $229.0M | $237.2M | $230.5M | $242.2M | $250.2M | $262.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.36B | $-1.37B | $-1.37B | $-1.37B | $-1.33B | $-1.32B | $-1.34B | $-1.32B |
| Total Stockholders' Equity | $19.7M | $7.1M | $-2.4M | $-10.9M | $29.5M | $16.3M | $-6.0M | $-453.0K |